Creegan & Nassoura Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.37M Hold
11,325
0.89% 40
2025
Q1
$1.26M Sell
11,325
-75
-0.7% -$8.36K 0.84% 42
2024
Q4
$1.11M Sell
11,400
-250
-2% -$24.3K 0.75% 46
2024
Q3
$1.34M Sell
11,650
-150
-1% -$17.3K 0.84% 43
2024
Q2
$1.26M Sell
11,800
-200
-2% -$21.3K 0.86% 42
2024
Q1
$1.16M Hold
12,000
0.78% 46
2023
Q4
$1.21M Hold
12,000
0.88% 42
2023
Q3
$1.22M Hold
12,000
0.95% 43
2023
Q2
$1.21M Sell
12,000
-650
-5% -$65.6K 0.89% 46
2023
Q1
$1.16M Hold
12,650
0.89% 42
2022
Q4
$1.15M Sell
12,650
-1,225
-9% -$111K 0.89% 43
2022
Q3
$1.06M Hold
13,875
0.91% 41
2022
Q2
$1.17M Sell
13,875
-875
-6% -$74K 0.99% 43
2022
Q1
$1.29M Sell
14,750
-5,675
-28% -$498K 0.97% 45
2021
Q4
$1.79M Hold
20,425
1.35% 32
2021
Q3
$1.67M Sell
20,425
-225
-1% -$18.4K 1.42% 28
2021
Q2
$1.88M Sell
20,650
-675
-3% -$61.6K 1.61% 25
2021
Q1
$1.82M Sell
21,325
-900
-4% -$76.9K 1.63% 26
2020
Q4
$2.1M Hold
22,225
2.02% 18
2020
Q3
$1.93M Hold
22,225
2.08% 16
2020
Q2
$1.94M Sell
22,225
-50
-0.2% -$4.37K 2.19% 15
2020
Q1
$1.84M Hold
22,275
2.4% 11
2019
Q4
$2.11M Buy
+22,275
New +$2.11M 2.12% 16
2016
Q3
$2.07M Sell
29,183
-112
-0.4% -$7.93K 2.41% 11
2016
Q2
$2.17M Sell
29,295
-670
-2% -$49.5K 2.56% 9
2016
Q1
$1.95M Sell
29,965
-418
-1% -$27.1K 2.3% 11
2015
Q4
$2.34M Sell
30,383
-112
-0.4% -$8.63K 2.66% 7
2015
Q3
$2.51M Sell
30,495
-111
-0.4% -$9.14K 2.86% 4
2015
Q2
$2.7M Hold
30,606
2.81% 3
2015
Q1
$2.7M Sell
30,606
-670
-2% -$59.2K 2.78% 2
2014
Q4
$2.6M Buy
+31,276
New +$2.6M 2.65% 5